Is TXG or WEAV more undervalued in 2026?

CirclFi compares 10x Genomics, Inc. (TXG) and Weave Communications, Inc. (WEAV) using 13 institutional-grade valuation models. TXG has a Quality of Company score of 8.3/10 while WEAV scores 6.5/10.

Which is a better buy — TXG or WEAV?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do TXG and WEAV valuations compare?

TXG at $27.99 and WEAV at $5.76 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

TXG vs WEAV Valuation Comparison 2026 — Intrinsic Value Analysis

TXG

Health Information Services

10x Genomics, Inc.

Quality

8.3

out of 10

Value Trap

SAFE

Price

$27.99

Last close

Models

13/13

Active

WEAV

Health Information Services

Weave Communications, Inc.

Quality

6.5

out of 10

Value Trap

WARN

Price

$5.76

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	TXG Fair Value	TXG Upside	WEAV Fair Value	WEAV Upside
Bayesian DCF	Intrinsic	$21.21	-24.2%	$1.17	-79.7%
Earnings Power Value	Intrinsic	$5.32	-81.0%	$7.38	+28.3%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for TXG vs WEAV — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TXG vs WEAV — Which Stock Is More Undervalued?

TXG scores higher with a 8.3/10 quality rating vs WEAV's 6.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing 10x Genomics, Inc. (TXG) and Weave Communications, Inc. (WEAV) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TXG currently trades at $27.99 with a QOC of 8.3/10, while WEAV trades at $5.76 with a QOC of 6.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).